EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death

Mariaconcetta Sicurella iD, Marica De Chiara, Luca Maria Neri iD

Cells · 13.02.2025 · 14 (4) · 269

DOI: 10.3390/cells14040269 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 13.02.2025. Verfasst von Mariaconcetta Sicurella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Signal Transduction, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ferrara, Fondo di Ateneo per la Ricerca Scientifica (FAR), Fondazione Di Bella.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hedgehog (Hh) and PI3K/Akt/mTOR signaling pathways play a pivotal role in driving the initiation and progression of various cancers, including hematologic malignancies such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL). These pathways are often dysregulated in leukemia cells, leading to increased cell growth, survival, and drug resistance while also impairing mechanisms of cell death. In leukemia, the Hh pathway can be abnormally activated by genetic mutations. Additionally, the PI3K/Akt/mTOR pathway is frequently overactive due to genetic changes. A key aspect of these pathways is their interaction: activation of the PI3K/Akt pathway can trigger a non-canonical activation of the Hh pathway, which further promotes leukemia cell growth and survival. Targeted inhibitors of these pathways, such as Gli inhibitors and PI3K/mTOR inhibitors, have shown promise in preclinical and clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesSignal TransductionProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesHedgehog ProteinsLeukemiaHumansCell DeathAnimals

Stichwörter der Autor:innen

Hedgehog (Hh) signalingPI3K/Akt/mTOR pathwayapoptosisautophagyleukemia

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesHedgehog ProteinsMTOR protein, human

Autor:innen und Institutionen

  • Department of Environmental Sciences and Prevention, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
  • LTTA-Electron Microscopy Center, University of Ferrara, 44121 Ferrara, Italy.

ORCID-Profile: Mariaconcetta Sicurella, Luca Maria Neri

Förderung

  • University of Ferrara
  • Fondo di Ateneo per la Ricerca Scientifica (FAR)
  • Fondazione Di Bella
  • Fondo per l’incentivazione alla Ricerca Dipartimentale (FIRD 2022)

Zitieren

APA

Sicurella, M., De Chiara, M., & Neri, L. M. (2025). Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death. Cells, 14(4), 269. https://doi.org/10.3390/cells14040269

Vancouver

Sicurella M, De Chiara M, Neri LM. Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death. Cells. 2025;14(4):269. doi:10.3390/cells14040269

BibTeX
@article{Sicurella2025,
  author = {Sicurella, Mariaconcetta and De Chiara, Marica and Neri, Luca Maria},
  title = {Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {269},
  doi = {10.3390/cells14040269}
}
Kostenlos starten →